Premarket analyst action – healthcare


© Reuters.  Premarket analyst action - healthcare© Reuters. Premarket analyst action – healthcare

  • Sucampo Pharmaceuticals (NASDAQ:SCMP) initiated with Buy rating and $14 (36% upside) price target by B. Riley.
  • TG Therapeutics (NASDAQ:TGTX) assumed with Buy rating and $33 (300% upside) price target by H.C. Wainwright citing bullish prospects for ublituximab and umbralisib.
  • Perrigo (NASDAQ:PRGO) upgraded to Market Perform with an $80 (8% downside risk) price target by I.B.I.
  • Mirati Therapeutics (NASDAQ:MRTX) upgraded to Outperform by Leerink. Shares up 6% premarket on light volume.
  • ADMA Biologics (NASDAQ:ADMA) upgraded to Outperform by Raymond James. Shares up 9% premarket but only on 900 shares.
  • Zimmer Biomet Holdings (NYSE:ZBH) upgraded to Buy by Deutsche Bank (DE:DBKGn).
  • BeiGene (NASDAQ:BGNE) downgraded to Neutral with an $83 (flat) price target by Baird citing valuation.
  • Now read: Perrigo Company 2017 Q3 – Results – Earnings Call Slides

Original article

sponsoredArticle = ‘div-gpt-ad-1466339494851-0’;